E-LIB Suche - Ergebnisse für: Shoushtari, Alexander N

1

The features and management of acquired resistance to PD1-b..:

Hepner, Adriana ; Versluis, Judith M. ; Wallace, Roslyn...
European Journal of Cancer. 196 (2024) - p. 113441 , 2024

2

Clearance of plasma cell free DNA in metastatic uveal melan..:

Francis, Jasmine H. ; Barker, Christopher A. ; Canestraro, Julia..
American Journal of Ophthalmology Case Reports. 34 (2024) - p. 102021 , 2024

Link: https://doi.org/10.1016/..

3

Long-term survival follow-up for tebentafusp in previously ..:

Sacco, Joseph J ; Carvajal, Richard D ; Butler, Marcus O...
Journal for ImmunoTherapy of Cancer. 12 (2024) 6 - p. e009028 , 2024

Link: https://doi.org/10.1136/..

4

More than Just Skin-Deep: A Review of Imaging's Role in Gui..:

Prendergast, Conor M. ; Capaccione, Kathleen M. ; Lopci, Egesta...
Diagnostics. 13 (2023) 5 - p. 992 , 2023

Link: https://doi.org/10.3390/..

5

Tebentafusp in combination with durvalumab and/or tremelimu..:

Hamid, Omid ; Hassel, Jessica C ; Shoushtari, Alexander N...
Journal for ImmunoTherapy of Cancer. 11 (2023) 6 - p. e006747 , 2023

Link: https://doi.org/10.1136/..

6

Undifferentiated and Dedifferentiated Metastatic Melanomas ..:

Kasago, Israel S. ; Chatila, Walid K. ; Lezcano, Cecilia M....
Modern Pathology. 36 (2023) 8 - p. 100165 , 2023

Link: https://doi.org/10.1016/..

7

Most large structural variants in cancer genomes can be det..:

Choo, Zi-Ning ; Behr, Julie M. ; Deshpande, Aditya...
Nature Genetics. 55 (2023) 12 - p. 2139-2148 , 2023

Link: https://doi.org/10.1038/..

8

Determinants of overall survival in patients with metastati..:

Demkowicz, Patrick ; Pointdujour‐Lim, Renelle ; Miguez, Sofia...
Cancer. 129 (2023) 20 - p. 3275-3286 , 2023

Link: https://doi.org/10.1002/..

9

Beyond the 5‐year milestone: Long‐term survivorship of mela..:

Loo, Kimberly ; Kalvin, Hannah L. ; Panageas, Katherine S....
Pigment Cell & Melanoma Research. 36 (2023) 3-4 - p. 314-320 , 2023

Link: https://doi.org/10.1111/..

10

Author Correction: Neoadjuvant relatlimab and nivolumab in ..:

Amaria, Rodabe N. ; Postow, Michael ; Burton, Elizabeth M....
Nature. 615 (2023) 7953 - p. E23-E23 , 2023

Link: https://doi.org/10.1038/..

11

Decision-Making and Health-Related Quality of Life in Patie..:

Atkinson, Thomas M ; Hay, Jennifer L ; Young Kim, Soo...
The Oncologist. 28 (2023) 4 - p. 351-357 , 2023

Link: https://doi.org/10.1093/..

12

Proceedings from the Melanoma Research Foundation Mucosal M..:

Wei, Alexander Z. ; Chen, Lanyi N. ; Orloff, Marlana...
Pigment Cell & Melanoma Research. 36 (2023) 6 - p. 542-556 , 2023

Link: https://doi.org/10.1111/..

13

Combination intravitreous melphalan and bevacizumb for cuta..:

Francis, Jasmine H. ; Canestraro, Julia ; Abramson, David H...
American Journal of Ophthalmology Case Reports. 26 (2022) - p. 101519 , 2022

Link: https://doi.org/10.1016/..

14

Nivolumab versus placebo as adjuvant therapy for resected s..:

Weber, Jeffrey S. ; Poretta, Tayla ; Stwalley, Brian D....
Cancer Immunology, Immunotherapy. 72 (2022) 4 - p. 945-954 , 2022

Link: https://doi.org/10.1007/..

15

Urethral Melanoma – Clinical, Pathological and Molecular Ch..:

Mano, Roy ; Hoeh, Benedikt ; DiNatale, Renzo G....
Bladder Cancer. 8 (2022) 3 - p. 291-301 , 2022

Link: https://doi.org/10.3233/..